https://www.indianpharmapost.com/fda-nod-to-first-oral-single-dose-treatment-for-gonorrhea-185602025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/alphyn-biologics-bags-25-million-financing-to-advance-breakthrough-skin-disease-therapies-185752025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/zenas-biopharma-and-innocare-hit-key-milestone-in-lupus-drug-trial-secures-china-phase-3-nod-185742025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/sobi-to-acquire-arthrosi-therapeutics-in-950-million-deal-bolstering-gout-pipeline-185732025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/neuren-partner-acadia-bags-fda-go-ahead-for-new-daybue-stix-powder-for-rett-syndrome-185722025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofi-secures-two-breakthrough-nods-in-china-for-rare-blood-disorders-185712025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/sanofi-flags-delay-in-fda-review-of-tolebrutinib-for-progressive-multiple-sclerosis-185702025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/pharma-overhaul-ema-hails-once-in-a-generation-reform-185692025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/godavari-biorefineries-ed-sangeeta-srivastava-named-brsi-honorary-fellow-185682025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-launches-its-glucagon-like-peptide-1-liraglutide-in-the-netherlands-185672025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/shelter-pharma-launches-d3-cure-capsules-185662025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/kims-hospital-bengaluru-commences-operations-at-pes-university-campus-185652025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/ind-swift-laboratories-receives-gmp-compliance-certificate-from-nngyk-hungary-185642025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-accepts-sentynl-therapeutics-cutx-101-nda-resubmission-185632025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/accenture-invests-in-ryght-ai-to-revolutionize-clinical-trials-185622025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/immunitybios-anktiva-wins-ema-nod-for-early-eu-approval-in-hard-to-treat-bladder-cancer-185612025-12-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/anova-launches-ai-powered-patient-matching-platform-to-speed-clinical-trial-enrollment-185762025-12-16T00:00:00+05:30always0.9